Publication | Open Access

Phase I trial of a murine antibody to MUC1 in patients with metastatic cancer: evidence for the activation of humoral and cellular antitumor immunity

Cancer ImmunosurveillanceMedicineImmunologyTumor ImmunityCellular Antitumor ImmunityImmunoeditingMurine AntibodyImmunotherapyOncologyRadiation OncologyMetastatic Cancer